Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for NHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -9.521M
March 31, 2026 -54.18M
December 31, 2025 -43.37M
September 30, 2025 -47.00M
June 30, 2025 -33.04M
March 31, 2025 -12.69M
December 31, 2024 1.369B
September 30, 2024 -1.250B
June 30, 2024 -7.613M
March 31, 2024 -12.07M
December 31, 2023 -9.834M
September 30, 2023 -9.82M
June 30, 2023 -10.27M
March 31, 2023 -12.62M
December 31, 2022 -12.10M
September 30, 2022 -16.74M
June 30, 2022 -8.347M
March 31, 2022 -10.70M
December 31, 2021 -8.531M
September 30, 2021 -9.727M
June 30, 2021 -6.894M
March 31, 2021 -9.148M
December 31, 2020 -8.37M
September 30, 2020 -9.091M
June 30, 2020 -58.28M
Date Value
March 31, 2020 31.36M
December 31, 2019 -27.85M
September 30, 2019 -35.08M
June 30, 2019 -7.941M
March 31, 2019 -8.875M
December 31, 2018 -27.61M
September 30, 2018 -18.54M
June 30, 2018 -22.96M
March 31, 2018 -8.159M
December 31, 2017 -27.04M
September 30, 2017 -7.961M
June 30, 2017 -6.04M
March 31, 2017 -8.033M
December 31, 2016 -6.512M
September 30, 2016 -16.02M
June 30, 2016 -6.28M
March 31, 2016 1.683M
December 31, 2015 -26.80M
September 30, 2015 -5.73M
June 30, 2015 -7.068M
March 31, 2015 -2.079M
December 31, 2014 -7.331M
September 30, 2014 -14.89M
June 30, 2014 -7.345M
March 31, 2014 -0.556M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
The Ensign Group, Inc. -41.45M
Regional Health Properties, Inc. -0.388M
Chemed Corp. -33.21M
InnovAge Holding Corp. -2.006M
The Pennant Group, Inc. 28.45M